2. Nitti V.W., Kim Y., Combs A.J. Voiding dysfunction following transurethral resection of the prostate: symptoms and urodynamic findings. J Urol. 1997; 157:600–603.

3. Cho M.C., Kim H.S., Lee C.J. et al. Influence of detrusor overactivity on storage symptoms following potassium titanyl-phosphate photoselective vaporization of the prostate. Urology. 2010; 75:1460–1466.

4. Al-Rawashdah S.F., Pastore A.L., Salhi Y.A. et al. Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes. World J Urol. 2017;35: 1595–601.

5. Skolarikos A., Rassweiler J., de la Rosette J.J. et al. Safety and efficacy of bipolar versus monopolar transurethral resection of the prostate in patients with large prostates or severe lower urinary tract symptoms: post hoc analysis of a European multicenter randomized controlled trial. J Urol. 2016; 195:677–684.

6. Thomas J.A., Tubaro A., Barber N. et al. A multicenter randomized noninferiority trial comparing Green Light-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol. 2016; 69:94–102.

7. Mordasini L., Di Bona C., Klein J. et al. 80W Green Light laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic obstruction: 5-year outcomes of a single-center prospective randomized trial. Urology. 2018; 116:144–149.

8. Bae J., Kang H.W., Lee H.W. et al. Predictors of de novo urge urinary incontinence after photoselective vaporization of the prostate. World J Urol. 2016; 34:413–418.

9. Mirone V., Imbimbo C., Longo N., Fusco F. The detrusor muscle: an innocent victim of bladder outlet obstruction. Eur Urol. 2007;51: 57–66.

10. Pinggera G.-M., Mitterberger M., Pallwein L. et al. Alpha-blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms. BJU Int. 2008; 101:319–424.

11. Lin Y.-H., Hou C.-P., Chen T.-H. et al. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan nationwide population-based cohort study. Clin Interv Aging. 2017; 12:535–541.

12. Barbosa J.A.B.A., Reis S.T., Nunes M. et al. The obstructed bladder: expression of collagen, matrix metalloproteinases, muscarinic receptors, and angiogenic and neurotrophic factors in patients with benign prostatic hyperplasia. Urology. 2017; 106:167–172.

13. Wu Y., Pan H., Wang W.-M. et al. A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection. Asian J Androl. 2017;19:230–233.

14. Huet R., Mathieu R., Rohou T. et al. MRI assessment of tissue effects after 180-W XPS greenlight laser vaporization of the prostate. Lasers Surg Med. 2017; 49:577–81.

15. Antunes A.A., Iscaife A., Reis S.T. et al. Can we predict which patients will experience resolution of detrusor overactivity after transurethral resection of the prostate? J Urol. 2015; 193:2028–2032.

16. Choi H., Kim J.H., Shim J.S. et al. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement. Urol Int. 2014; 93:425–430.

17. Hu H., Zhang W., Liu X. et al. Nerve growth factor levels are associated with overactive bladder symptoms and long-term treatment outcome after transurethral resection of the prostate in patients with benign prostate hyperplasia. J Urol. 2018 (in press).

18. Chughtai B., Simma-Chiang V., Kaplan S.A. Evaluation and management of post-transurethral resection of the prostate lower urinary tract symptoms. Curr Urol Rep. 2014; 15:434.

19. Rassweiler J., Teber D., Kuntz R., Hofmann R. Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol. 2006;50:969–79. discussion 980

20. Pereira-Correia J.A., de Moraes Sousa K.D., Santos J.B.P. et al. GreenLight HPS™120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int. 2012; 110:1184–1189.

21. Kuo H.-C. Analysis of the pathophysiology of lower urinary tract symptoms in patients after prostatectomy. Urol Int. 2002;68:99–104.

22. Kahokehr A., Vather R., Nixon A., Hill A.G. Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials. BJU Int. 2013; 111:304–311

23. Martov A.G., Ergakov D.V.

24. Litman H.J., Bhasin S., O’Leary M.P., et al. BACH Survey Investigators. An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey. BJU Int. 2007;100:321–326.

25. Han H.H., Ko W.J., Yoo T.K., et al. Factors associated with continuing medical therapy after transurethral resection of prostate. Urology 2014; 84: 675–680.

26. Kim S.-J., Al Hussein Alawamlh O., Chughtai B. et al. Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate. Current Urology Reports (2018) 19:85.

27. Hosier G.W., Tennankore K..K, Himmelman J.G, et al. Overactive bladder and storage lower urinary tract symptoms following radical prostatectomy. Urology 2016; 94: 193–197.

28. Cho M.-C., Yoo S., Park J. et al. Effect of preoperative detrusor underactivity on long-term surgical outcomes of photovaporization and holmium laser enucleation in men with benign prostatic hyperplasia: A lesson from five-year serial follow-up data. BJU, 2019: Doi: 10.1111/bju.14661.

29. Seki N., Yuki K., Takei M. et al. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction. Neurourol Urodyn. 2009;28:197–201.

30. Topazio L., Perugia C., De Nunzio C. et al. Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study. Urology (2018) 18:6.

31. Wang D., Huang H., Law Y.-M. et al. Relationships between Prostatic Volume and Intravesical Prostatic Protrusion on Transabdominal Ultrasound and Benign Prostatic Obstruction in Patients with Lower Urinary Tract Symptoms. Ann Acad Med Singapore 2015;44:60–65.

32. El-Tatawy H., Gameel T., Abo El-enen M. et al. Clinical significance of prostatic-urethral angulation on the treatment outcome of patients with symptomatic benign prostatic hyperplasia treated with tamsulosin hydrochloride. Archivio Italiano di Urologia e Andrologia 2015;87,3;238–242.

33. Hu H., Zhang W., Liu X. et al. Nerve growth factor levels are associated with overactive bladder symptoms and long-term treatment outcome after transurethral resection of the prostate in patients with benign prostate hyperplasia. J Urol. 2018;

34. Gacci M., Sebastianelli A., Salvi M., et al. The impact of central obesity on storage LUTS and urinary incontinence after prostatic surgery. Curr Urol Rep 2016;17:61.

35. Inamura S., Ito H., Shinagawa T., et al. Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia. The Prostate. 2018;1–10.

36. Kaplan S.A., McCammon K., Fincher R., et al. Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency. J Urol 2009; 182: 2825–2830.

37. Matsuo T., Miyata Y., Kakoki K., et al. The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly men. BMC Urol 2016;16:45.

38. Porru D., Campus G., Caria A. et al. Impact of early pelvic floor rehabilitation after transurethral resection of the prostate. Neurourol Urodyn. 2001;20:53.

39. Hou C.-P., Chen T.-Y., Chang C.-C. et al. Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery. Clin Interv Aging. 2013;8:667–673.

40. Jiang Y.-H., Liao C.-H., Kuo H.-C. How much improvement is needed for a real difference of lower urinary tract symptoms after long-term combination therapy for benign prostatic hyperplasia. Int J Clin Pract. 2014;68(9):1081–1086.